MALT1 inhibitors (Medivir/Uppsala University)

N/A

Report date: 2025/03/20 15:20:00
NME

Base Information

Drug NameMALT1 inhibitors (Medivir/Uppsala University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetastasis Associated Lung Adenocarcinoma Transcript 1 inhibitors
TargetsMetastasis Associated Lung Adenocarcinoma Transcript 1
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedivir AB
China Registration ClassN/A

Develop Information

Active CompaniesMedivir ABUppsala University
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A